Prostate Cancer

Gene therapy may be a cure for post-radical prostatectomy erectile dysfunction

Published in Gene Therapy Weekly, May 22nd, 2003

Researchers from the University of Pittsburgh Medical Center (UPMC) have found that gene therapy may not only be a feasible, but also may be an ideal treatment for neuropathic erectile dysfunction (ED).

Neuropathic ED results from damage to the nerves essential to achieving and maintaining an erection and is experienced by 79.6% of men who undergo radical prostatectomies. Results of the study were presented at the annual meeting of the American Urological Association (AUA) and are published in abstract 1179 of the AUA proceedings.

"While radical prostatectomy can be a cure for early stage prostate cancer in a large percentage of patients, there are a...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2003-05-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry